Fisher & Paykel Healthcare Corporation Limited (FPH) Stock Statistics & Valuation Metrics

Fisher & Paykel Healthcare Corporation Limited has a market cap or net worth of NZD 28.04B. The enterprise value is NZD 21.78B.

Market Cap

NZD 28.04B

Enterprise Value

NZD 21.78B

Fisher & Paykel Healthcare Corporation Limited has 588,265,440 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

588,265,440

Owned by Insiders

0.17%

Owned by Institutions

15.35%

Fisher & Paykel Healthcare Corporation Limited’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 20.72%.

Return on Equity (ROE)

0.22

Return on Assets (ROA)

0.16

Return on Invested Capital (ROIC)

20.72%

Return on Capital Employed (ROCE)

0.28

Revenue Per Employee

316.25K

Profits Per Employee

63.35K

Employee Count

7,396

Asset Turnover

0.82

Inventory Turnover

2.56

The current PE Ratio of Fisher & Paykel Healthcare Corporation Limited is 57.38. Fisher & Paykel Healthcare Corporation Limited’s PEG ratio is 1.61.

PE Ratio

57.38

PS Ratio

11.53

PB Ratio

12.74

Price to FCF

54.97

Price to Operating Cash Flow

40.62

PEG Ratio

1.61

In the last 12 months, Fisher & Paykel Healthcare Corporation Limited had revenue of 2.34B and earned 468.50M in profits. Earnings per share was 0.80.

Revenue

2.34B

Gross Profit

1.50B

Operating Income

667.00M

Pretax Income

631.50M

Net Income

468.50M

EBITDA

825.60M

Earnings Per Share (EPS)

0.80

In the last 12 months, operating cash flow was 663.20M and capital expenditures -172.80M, giving a free cash flow of 490.40M billion.

Operating Cash Flow

663.20M

Free Cash Flow

490.40M

Free Cash Flow per Share

0.84

Fisher & Paykel Healthcare Corporation Limited pays an annual dividend of NZD 0.39, resulting in a dividend yield of 1.59%

Dividend Per Share

NZD 0.39

Dividend Yield

1.59%

Payout Ratio

28.29%

Free Cash Flow Yield

1.81%

Earnings Yield

1.73%

Beta

1.71

52-Week Price Change

24.34%

50-Day Moving Average

45.99

200-Day Moving Average

40.15

Relative Strength Index (RSI)

53.96

Average Volume (3m)

474.62K

Fisher & Paykel Healthcare Corporation Limited upcoming earnings date is Nov 25, 2026, After Close (Not Confirmed).

Last Earnings Date

May 25, 2026

Next Earnings Date

Nov 25, 2026

Ex-Dividend Date

Jun 21, 2026

Fisher & Paykel Healthcare Corporation Limited as a current ratio of 2.31, with Debt / Equity ratio of 6.91%

Current Ratio

2.31

Quick Ratio

1.66

Debt to Market Cap

0.00

Net Debt to EBITDA

-0.38

Interest Coverage Ratio

64.76

In the past 12 months, Fisher & Paykel Healthcare Corporation Limited has paid 163.00M in taxes.

Income Tax

163.00M

Effective Tax Rate

0.26

Fisher & Paykel Healthcare Corporation Limited EV to EBITDA ratio is 32.79, with an EV/FCF ratio of 54.60.

EV to Sales

11.45

EV to EBITDA

32.79

EV to Free Cash Flow

54.60

EV to Operating Cash Flow

40.38

Fisher & Paykel Healthcare Corporation Limited has NZD 461.10M in cash and marketable securities with NZD 146.10M in debt, giving a net cash position of NZD 315.00M billion.

Cash & Marketable Securities

NZD 461.10M

Total Debt

NZD 146.10M

Net Cash

NZD 315.00M

Net Cash Per Share

NZD 0.54

Tangible Book Value Per Share

NZD 3.48

Gross margin is 64.16%, with operating margin of 28.52%, and net profit margin of 20.03%.

Gross Margin

64.16%

Operating Margin

28.52%

Pretax Margin

27.00%

Net Profit Margin

20.03%

EBITDA Margin

34.92%

EBIT Margin

28.14%

The average price target for Fisher & Paykel Healthcare Corporation Limited is NZD 51.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

NZD 51.25

Price Target Upside

11.11% Upside

Analyst Consensus

Strong Buy

Analyst Count

8

Revenue Growth Forecast

15.59%

EPS Growth Forecast

23.94%

Smart Score

―

AI Score

80